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Abstract Myocardial infarction (MI) is caused by the
occlusion of a coronary artery due to underlying
atherosclerosis complicated by localized thrombosis. The
blockage of blood flow leads to cardiomyocyte (CM) death
in the infarcted area. Adult mammalian cardiomyocytes
have little capacity to proliferate in response to injury;
however, some pathways active during embryogenesis and
silent during adult life are recruited in response to tissue
injury. One such example is hedgehog (Hh) signaling. Hh
is involved in the embryonic development of the heart and
coronary vascular system. Pathological conditions includ-
ing ischemia activate Hh signaling in adult tissues. This
review highlights the involvement of Hh signaling in
ischemic tissue regeneration with a particular emphasis on
heart regeneration and discusses its potential role as a
therapeutic agent.
Keywords Hedgehog  Heart regeneration 
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Introduction
Myocardial infarction (MI) is caused by the occlusion of a
coronary artery due to atherothrombosis. Blood flow to the
heart muscle is blocked resulting in cardiomyocyte (CM)
death in the infarcted area. As a consequence, progressive
and negative left ventricular remodeling (LV) and scar
tissue formation take place [1]. After MI many CMs are
lost and replaced by activated fibroblasts that cannot con-
tribute to the contractile activity of the myocardium. Thus,
the ischemic myocardium requires regeneration of dam-
aged tissues such as cardiac muscle as well as heart
vasculature. In general, the human body has mechanisms to
partially compensate these losses but they are insufficient
to restore heart function. Adult mammalian heart CMs have
little capacity to proliferate in response to injury. The
majority of cardiomyocytes stops proliferation shortly after
birth [2], although continuous cardiomyocyte turnover has
been detected in adult mouse and human hearts [3, 4].
Enhancement of this endogenous capability to regenerate
can be considered as a strategy to develop cardiac regen-
eration therapies.
It has become evident that some pathways active during
embryogenesis and silent during adult life are recruited in
response to tissue injury and regeneration. Among them is
hedgehog (Hh) signaling. The process of regeneration
includes such events as cellular proliferation, differentia-
tion and dedifferentiation. Hh signaling controls both cell
proliferation and differentiation and it is involved in cell
cycle regulation. Hh is implicated in the regulation of
embryonic heart and coronary vascular system develop-
ment [5–7]. Hh signaling components are also present in
adult cardiovascular tissues, although its activity is at a
very low level. Pathological conditions such as ischemia
reactivate Hh signaling. This review summarizes and
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discusses the data which support the role of Hh signaling in
myocardial regeneration and blood vessel repair.
Hedgehog signaling
Sonic hedgehog (Shh), Indian hedgehog (Ihh), and Desert
hedgehog (Dhh) are secreted signaling proteins, which act as
morphogens during embryonic development. The Hh sig-
naling pathway is initiated by the binding of Hh proteins to
Patched1 (Ptc1) or Patched2 (Ptc2) receptors. In the absence
of Hh proteins, the 12-transmembrane receptor Ptc1 inhibits
activity of smoothened (Smo), a 7-transmembrane protein
that regulates activation of the Glioma-associated oncogene
homologue (Gli) family of transcription factors; Gli1, Gli2,
and Gli3 [8]. In the presence of Hh proteins, Ptc1 is inter-
nalized and Smo is released from repression. This step leads
to the dissociation of a cytosolic complex with Glis and their
subsequent translocation into nucleus to transduce Hh sig-
naling. Gli1 itself, Ptc1 and Ptc2 are Gli-target genes and
upregulation of their expression can serve as a marker for Hh
signaling activation. Moreover, upregulation of Ptc1 and
Ptc2 in response to Hh signaling creates a negative feedback
loop to regulate Hh protein distribution and the level of Hh
pathway activation. The activation of the pathway via Gli-
dependent transcription is considered as a ‘‘canonical’’
response to Hh. Hh proteins can also stimulate Gli-inde-
pendent pathways, which involve either Ptc1 activity
without its inhibitory activity on Smo, or Smo activity
without Gli regulation (noncanonical Hh signaling) [9].
Hh in heart regeneration of lower vertebrates
Zebrafish
As indicated above, the signaling pathways that regulate
cardiac development are often reactivated during heart
repair in response to injury. Several studies on zebrafish
embryos implicated Hh signaling in cardiac development.
Genetic or pharmacological inhibition or activation of Hh
signaling in zebrafish embryos revealed that Hh signaling
is involved in cardiomyocyte formation via specification of
myocardial progenitors during gastrulation and early
somitogenesis stages [10]. Furthermore, monitoring of
cardiomyocyte proliferation in live zebrafish embryo using
the FUCCI technology demonstrated the role of Hh sig-
naling also in cardiac proliferation. The treatment of
embryos with either Hh signaling Smoothened agonist
(SAG) or antagonist cyclopamine (CyA) increased or
reduced the number of proliferating cardiomyocyte,
respectively [11]. These results clearly indicate that Hh
signaling is crucial for cardiomyocyte formation and pro-
liferation in the zebrafish embryo.
Zebrafish models have also been used to study the car-
diac recovery in response to injury due to the ability to
effectively regenerate their heart. To check whether heart
injury activated Hh signaling during regeneration, Choi
et al. [11] generated two transgenic reporter zebrafish lines
in which enhanced green fluorescent protein (EGFP)
expression was under the control of either Shh or Ptc2
promoter. Analysis of expression of Hh signaling compo-
nents after partial ventricular resection of adult zebrafish
heart has shown the upregulation of Shh in epicardial cells
within the injury. Upregulation of ptch2 in cardiomyocytes
in the area of regeneration was a marker of Hh signaling
activation. In addition, similar to the zebrafish embryo,
treatment of animals with CyA for 6 days after ventricle
resection or diffuse genetic ablation of cardiomyocytes
displayed a decrease of cardiomyocyte proliferation.
A recent study on genetic depletion of the epicardium in
adult zebrafish identified Hh signaling as a mediator of epi-
cardial regeneration [12]. The epicardium depletion resulted
in delay of the whole repair process. The heart regeneration
after myocardial loss was completed only after the epi-
cardium recovery which was dependent on Shh. Treatment
with Shh enhanced epicardial response to injury, whereas
inhibition of Hh signaling with CyA blocked regeneration of
cardiac explants ex vivo through reduced epicardial cell
proliferation promoted by endogenous Hh signaling.
Newt
Likewise, adult newts have the ability to regenerate heart
[13] as well as spinal cord and neuronal tissues [14], retina
and lens [15], and limbs [16]. Involvement of Hh signaling in
regeneration of lens, limb bud, tail, and heart of embryos and
adult newts has also been investigated [17–20]. In general,
injury resulted in upregulation of Shh and Ptc1 expression in
regenerating tissues. In case of heart, the resection study on
adult newt heart demonstrated upregulation of Shh and Ptc1
proteins in epicardial and myocardial cells [20]. Interference
with Hh signaling led to repression of regeneration process,
including cell proliferation.
Taken together, upregulation of Hh signaling as a
response to heart injury is common for zebrafish and newt.
It seems likely that Shh activated in epicardium is
responsible for increased proliferation of cardiomyocytes
via Ptc receptors.
Hh in heart regeneration of mammals
Fetal and neonatal rodents
Similar to zebrafish and amphibians, fetal and neonatal
mice show a robust capacity for cardiac regeneration after
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injury [21, 22]. However, the neonatal mouse heart retains
regenerative potential for only 7 days after birth [22].
Nothing is known about the involvement of Hh signal-
ing in regeneration of fetal or neonatal rodent hearts.
However, intact Hh signaling has been demonstrated in
neonatal ventricular myocytes isolated from 1 to 3 days rat
pups (NRVM). Incubation of NRVMs with recombinant
Shh resulted in upregulation of Gli1 and Ptc1 genes and
treatment with CyA abolished this response suggesting that
these cells are Hh responsive [23]. Responsiveness of
neonatal rat primary cardiac cells to Shh protein has also
been observed by other groups [24, 25]. Pretreatment of
these cells with either free recombinant Shh or incorpo-
rated in a coacervate, a delivery system comprised of
heparin and a synthetic polycation, reduced apoptosis
levels compared to the H2O2 treated control group. Toge-
ther, these results indicate Hh signaling is functional in
neonatal murine cardiomyocytes and might participate in
cardiac regeneration in response to heart injury.
Adult rodents
Hh signaling has also been implicated in adult heart
homeostasis and in response to heart injury. In rodent adult
heart expression of Hh signaling components, especially
Ptc1, was detected in several resident cell populations:
perivascular interstitial fibroblasts [26], myocardial
fibroblasts and cardiomyocytes [24, 27] and endothelial,
medial and adventitial cells of cardiovascular tissue vas-
culature [28]. Thus, these cells can be targets of Hh
signaling.
The direct role of Hh signaling in homeostasis of adult
heart is rather controversial. Inactivation of Hh signaling
via Smo deletion in cardiomyocytes (Smomer) or in car-
diomyocytes and vascular smooth muscle cells
(Smomer,sm22) in mouse heart caused cardiomegaly, ven-
tricular dilation, impaired systolic function and fibrotic
replacement of myocardial tissue. Acute inhibition of
myocardial Hh signaling led to heart failure and subsequent
lethality due to coronary vascular disruption and tissue
hypoxia suggesting that Hh signaling is critical for adult
heart maintenance [26]. Another study reported that,
although both Ptc1 and Smo were expressed in adult car-
diomyocytes, inhibition of endogenous Hh signaling in rat
adult hearts with CyA did not have any effect on electro-
cardiogram (ECG) properties, indicating no presence of
active Hh signaling in the heart [29]. This apparent con-
tradiction between the two studies may be explained by the
fact that the elapsed time between treatment and exami-
nation of the animals differed. The animals in the latter
study were treated with CyA for only 6 h before ECG
analysis was performed. In comparison, 5 days passed
between the beginning of the treatment to ablate Smo and
subsequent analysis in the former study. Thus, the question
whether active Hh signaling is present in adult heart is still
open.
The presence of Hh signaling in adult heart and its
involvement in homeostasis also prompted studies on the
role of Hh signaling in response to cardiac ischemia.
Several groups used a model of acute MI induced by sur-
gical ligation of the left anterior descending artery (LAD).
Myocardial ischemia reactivated Hh signaling as Shh and
Ptc1 expressions were upregulated in the adult mouse heart
[24, 27, 30]. Furthermore, intramyocardial injection of
human Shh plasmid (phShh) immediately after LAD liga-
tion significantly reduced the infarct and fibrosis areas,
increased capillary density and a smooth muscle actin
(aSMA) positive cell area in the ischemic zone and
improved left ventricular function in rat hearts [24].
Likewise, intravenous injection of the recombinant Shh
homolog ligand (N-Shh) led to reduction of the infarct area
and subsequent arrhythmias [29]. In addition, both
endogenous and exogenous Shh prevented cardiac apop-
tosis induced by myocardial ischemia [24, 30]. Inhibition
of endogenous Hh with either neutralizing anti-mouse Shh
antibody [25] or Hh signaling antagonist SANT-1 [27] after
MI resulted in a significant increase of the infarct area,
border zone tissue hypoxia, and a reduction in border zone
coronary vessel density. Studies on mouse hindlimb
ischemia provided similar results; activation of endogenous
Hh signaling or administration of recombinant Shh or cells
modified to express Shh stimulated neovascularization in
different tissues (Table 1). Taken together, these results
clearly show a protective role of Hh signaling in response
to cardiac ischemia. Strikingly, Bijlsma et al. [30] have
shown that inhibition of endogenous Hh signaling with
CyA had a beneficial effect on ischemic myocardium in
mice; it restored ventricular function and decreased fibrosis
but it did not significantly affect vascularization. The rea-
son for this discrepancy is unclear, the experimental
settings were different and their direct comparison is rather
difficult. The authors assumed that the role of Hh signaling
might change during different phases of myocardial
ischemia. However, studies on Hh function during different
stages after infarction are needed to confirm this
assumption.
Cell-based therapy
The results described above demonstrate that Hh signaling
has a potential to preserve cardiac function and to influence
cardiac recovery in the context of myocardial ischemia. To
activate Hh pathway in ischemic heart, several cell-based
therapeutic strategies have been applied. CD34? cells are
hematopoietic cells that have been previously used for stem
cell therapy to preserve the functions of ischemic
Hh signaling in regeneration of the ischemic heart 3483
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Table 1 Effects of endogenous and exogenous Hh signaling on muscle regeneration
Hedgehog signaling members Effect References
Mouse ischemic hindlimb model (NLS-
Ptch-lacZ mice; surgically induced)
Endogenous
Hh signaling activation
1. Upregulation of Shh mRNA in ischemic skeletal
muscles particularly in the interstitial regions and
Shh and Ptc1 proteins in interstitial mesenchymal
fibroblasts
2. VEGF expression upregulation in interstitial
mesenchymal fibroblasts
3. Inhibition of Hh signaling with Hh-blocking
antibody (5E1) decreased blood flow and capillary
density
Pola et al.
[52]
Two mouse injury models: (1)
mechanical crush; (2) cardiotoxin
injection of the tibialis anterior (TA)
muscle
Endogenous Hh signaling
activation
1. In both models, Shh and Ptc1 mRNAs were
upregulated. Shh-positive signal was detected in
skeletal muscle fibers surrounding the injured area
2. Muscle satellite cells directly respond to Shh in the
setting of muscle injury in vivo; Ptc1 is
upregulated
3. Hh signaling inhibition results in impaired
production of angiogenic and myogenic secreted
factors, decreased upregulation of the Myf5 and
MyoD, impairment of the angiogenic response to
injury, reduction of the number of activated
satellite cells at the damage site, increased fibrosis
Straface
et al.
[53]
Mouse ischemic hindlimb model
(resection of the left femoral artery)
Endogenous Hh signaling
activation and exogenous
recombinant Shh
administration
1. Gli2 and Gli3 mRNA were overexpressed in the
ischemic tissue including myocytes and
endothelial cells
2. Overexpression of Gli2 and Gli3 in vitro promotes
myoblast survival and proliferation and EC
survival and migration as well as induce
expression of MMP-9 and osteopontin
3. Administration of the tibialis anterior muscles with
adenovirus encoding Gli2 and Gli3 led to higher
proliferation in the regenerating muscle
Renault
et al.
[54]
Mouse ischemic hindlimb model
(Gli3 ± mice; resection of the left
femoral artery)
Endogenous Hh signaling
suppression
1. Gli3?/– mice exhibit reduced capillary density
2. Gli3 overexpression in vitro led to increased Akt
phosphorylation, activation of the ERK1/2 and
increased c-Fos expression
Renault
et al.
[55]
Mouse ischemic hindlimb model (NLS-
Ptch-lacZ mice, surgically induced)
Intravascular injection of
exogenous recombinant Shh
1. The percentage of auto-amputated limbs and foot/
leg necrosis significantly decreased
2. A progressive increase in the blood flow; increased
numbers of capillaries, a substantial increase in
vessel diameter
3. Shh upregulated Ptc1, VEGF and Ang2 in cultured
fibroblasts
Pola
et al.[28]
Mouse ischemic hindlimb model (1 year
old mice)
Injection of a plasmid containing
the amino-terminal domain
coding the human Shh (phShh)
in 5 separate sites of the
hindlimb
1. Ischemia led to Gli1 upregulation in young but not
middle-aged mice
2. Ptc1 is robustly expressed in large areas of phShh-
treated middle-aged muscles, particularly in
interstitial fibroblasts
3. phShh treatment induced complete recovery of
blood flow in ischemic hindlimbs of middle-aged
mice. Capillary and arteriole density was
significantly increased compared with control
4. phShh treatment resulted in significant increase of
the number of circulating bone marrow derived
CD45-/Sca-1?/Flk-1? cells
5. phShh treatment resulted in upregulation of VEGF,
Ang-1 and SDF-1 in hindlimb muscles
Palladino
et al.
[56]
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myocardium or to treat refractory angina [31]. When
CD34? cells, genetically modified to express Shh
(CD34Shh), were injected into the border zone of mice with
acute MI, they induced a robust increase in border zone
capillary density accompanied by reduced infarct size in
comparison with unmodified CD34? cells or cells trans-
fected with the empty vector [32]. Mesenchymal stem cells
(MSCs) are potentially more pro-angiogenic and proarte-
riogenic than other types of stem cells [33]. Similar to
CD34Shh cells, injection of MSCs engineered to overex-
press Shh (MSCShh) in infarcted rat hearts resulted in
increased capillary development and density within the
infarct border zone, accompanied by reduced infarct sizes.
Thus, Shh improved functional preservation of cardiac
tissue compared with control cells [34]. Moreover, a high-
number of mature blood vessels (smooth muscle actin?
cells) were observed in mice treated with MSCShh. Fur-
thermore, genetic modification of MSCs with Shh
improved their survival and angiogenic potential in the
ischemic heart via upregulation of VEGF, Ang-1, iNOS,
netrin-1, hepatocyte growth factor (HGF), stromal cell-
derived factor 1a (SDF-1a) and insulin-like growth factor-1
(IGF-1).
Recent studies on rodent models of acute and chronic
MI reported that the effectiveness of pro-angiogenic gene
therapy could be improved by its combination with
progenitor cell mobilization. Indeed, Roncalli et al. [35]
demonstrated that Shh gene therapy in combination with
ADM3100-stimulated progenitor cell mobilization
(ADM3100 is a pharmacological agent that mobilizes
progenitor cells) reduced cardiac fibrosis and promoted the
development of capillaries and SMC containing vessels
after MI. This combinational therapy was more effective
than either treatment individually.
Hh signaling and cell reprogramming
Reprogramming of somatic cells into cardiomyocytes is
another strategy for regeneration of injured heart. Previous
studies identified adult cardiac fibroblasts as the most
abundant cell population in the heart and as a promising
cell source for reprogramming. However, recently Pinto
et al. [36] demonstrated that the most prominent heart cells
are endothelial cells (around 60%) but not fibroblasts
(under 20%). Nevertheless, reprogramming of scar forming
fibroblasts into beating cardiomyocytes would be a logical
step. Indeed, fibroblasts can be directly reprogrammed into
induced pluripotent stem cells (iPSCs) or into cardiomy-
ocytes through the forced expression of pluripotency genes
octamer-binding transcription factor 4 (OCT4), sex deter-
mining region Y box 2 (SOX2), Kruppel-Like factor 4
(KLF4) and V-Myc avian myelocytomatosis viral
Table 1 continued
Hedgehog signaling members Effect References
Mouse ischemic hindlimb model
(18 month mice)
Combined phShh and endothelial
progenitor cells (EPC) therapy
(intramuscular injection)
1. Combined therapy resulted in a significant increase
in capillary density compared to phShh gene
transfer or EPC administration
2. phShh therapy increased the incorporation of
transplanted EPCs into site of ischemia and
reduced their apoptosis
Palladino
et al.
[57]
Mouse ischemic hindlimb model (age
8–10 week)
Shh-treated human peripheral
blood derived CD34? locally
injected to lower limb muscles
1. Significant increase of blood perfusion ratio of
ischemic/non-ischemic hindlimbs in mice treated
with Shh-CD34? cells
2. The treatment with SHh-CD34? cells significantly
increased capillary density compared with the
control groups
3. Shh-CD34? cells showed better incorporation into
vascular structures in the ischemic limb muscles
4. Transplanted Shh-CD34? cells expressed VEGF-
A, while non-treated cells show no VEGF-A
expression
Kanaya
et al.
[58]
Mouse ischemic hindlimb model (12-
week-old Smo ± mice; resection of
the left femoral artery)
Endogenous Hh signaling
suppression
1. Ischemia-induced myogenesis and skeletal muscle
repair were delayed in Smo ± mice compared
with wild type mice.
Renault
et al.
[59]
Mouse ischemic hindlimb model
(streptozotocin induced type 1 diabetic
mice)
SAG treatment 1. SAG treatment increased capillary density and
blood perfusion in the ischemic hindlimb of
diabetic mice
2. SAG significantly increased the activity of AKT in
EPCs
Qin et al.
[60]
Hh signaling in regeneration of the ischemic heart 3485
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oncogene homolog (MYC) or GATA binding protein
(GATA4), myocyte enhancer factor 2C (Mef2c), and T-box
protein 5 (Tbx5), respectively [37, 38]. iPSCs also have the
ability to differentiate into cardiomyocytes [39, 40]. Cur-
rently, nothing is known about the role of Hh signaling in
fibroblast reprogramming into cardiomyocyte. However,
there are some indications that Hh signaling promotes
reprogramming of fibroblasts into other cell types. In com-
bination with OCT4 the activation of Hh signaling could
reprogram mouse embryonic and adult fibroblasts into
induced pluripotent stem cells (iPSCs) [41]. Moreover,
mouse fibroblasts could be directly reprogrammed into
midbrain dopaminergic neural progenitors by temporal
expression of the pluripotency factors and in the presence of
Shh and fibroblast growth factor 8 (FGF8) [42]. A combi-
nation of the transcription factors achaete-scute homolog 1
(Ascl1), nuclear receptor related 1 protein (Nurr1) with Shh
and FGF8b directly reprogrammed embryonic mouse
fibroblasts to induced neuronal cells [43].
The P19 cells, a pluripotent mouse embryonal carci-
noma stem cell line, can differentiate in vitro into multiple
cell types including cardiomyocytes. In the presence of
dimethyl sulfoxide (Me2SO), P19 cells aggregate and
spontaneously differentiate into beating cardiomyocytes
[44]. Activation of Hh signaling via overexpression of Shh
and Gli2 in aggregated P19 cells induced formation of
cardiomyocytes in the absence of Me2SO and led to
upregulation of expression of Ptc1, Gli1, Gli2 and cardiac
muscle transcription factors such as GATA binding protein
4 (Gata4), myocyte-specific enhancer factor C2 (MEF2C),
and Nkx2.5 [45]. Inhibition of Hh signaling via depletion
of CAM-related/downregulated by oncogenes (CDO), the
activator a Hh signaling, in P19 cells or mouse Cdo(-/-)
embryonic stem cells resulted in reduced expression Shh,
Gli1, Gata4, Nkx2.5 and MEF2C. Moreover, Cdo defi-
ciency caused a significant reduction in cardiomyocyte
differentiation and the formation of contractile colonies
[46]. These results suggested that Hh signaling was suffi-
cient to promote cardiomyogenesis and it can be used for
cellular reprogramming in vivo.
An overview of the different therapeutic strategies for
activating Hh signaling which were applied to target heart
regeneration and repair can be found in Fig. 1.
Future perspectives
There is a strong experimental basis for future studies on
the regenerative potential of Hh signaling in the heart. So
Fig. 1 Hh-based cardiac regeneration. Different therapeutic strategies which activated Hh signaling were applied to induce angiogenesis and to
target heart regeneration and repair
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far, most clinical data have been generated using Hh sig-
naling inhibitors as anticancer therapy in patients with
different types of tumors including prostate cancer, basic
cell carcinoma (BCC), and medulloblastoma. Increased
expression of Hh signaling components is usually observed
in tumors. Many small molecules with antagonistic effects
on various components of Hh signaling have been identi-
fied. Currently, around 90 studies have been either
initiated, running or completed with several compounds,
which inhibit either Smo or Gli proteins. The use of Hh
inhibitors as monotherapy in the clinical setting has been
effective for BCC and medulloblastoma. The results of
these trials indicate that Hh signaling is an attractive and
promising candidate for anticancer therapy.
In case of the ischemic heart, the activation of Hh sig-
naling protects against ischemic injuries. Several
therapeutic Hh agonists for ischemia treatment including
SAG were also proposed. SAG is a derivative of chlor-
obenzo thiophene that binds to and activated Smo. It has
been shown that up-regulation of the Hh pathway by SAG
was efficacious. However, whether SAG can be a proper
candidate has to be determined, since it crosses the gut, the
placenta and the blood barrier [47–49] and constitutive
activation of Hh signaling can result in tumor development.
Other Hh agonist drugs with a potential role in tissue
regeneration include four fluorinated glucocorticoids hal-
cinonide, fluticasone, clobetasol, and fluocinonide [50], all
FDA-approved compounds. These compounds have no
apparent association with topical cancers and have been
used to treat asthma, inflammation, and skin disease or
injury. It has also been shown that fluticasone is well tol-
erated orally [51]. However, their clinical relevance still
has to be evaluated.
Many other questions still have to be answered before
Hh based therapy can be applied clinically. What is the
molecular mechanism by which exogenous Hh affect in
ischemia-induced tissue injury? What component of Hh
signaling will be most useful as a target in a clinical set-
ting? Hh proteins are morphogens which have effect on
many cell types and cell responses are dependent on the
Fig. 2 Hh signaling mediates cell–cell cross talk in the ischemic
heart. A schematic representation of Hh signaling based cardiac cell
interactions. During heart injury it triggers expression of pro-
angiogenic cytokines and participates in repair by promoting cell
survival, proliferation and migration
Hh signaling in regeneration of the ischemic heart 3487
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dose of Hh proteins and time of exposure. Can Hh acti-
vation increase the potential risk for cancer induction? It is
important to determine such factors as right cell type, a
right dose, and duration of treatment.
Concluding remarks
Comparison of the Hh function in regeneration of ischemic
heart in lower vertebrates and mammals reveals both similari-
ties and differences. In general, Hh signaling reactivation is a
common response to heart ischemia. However, in lower ver-
tebrates, heart ischemia reactivates Hh signaling in epicardial
cells and this activation seems essential for cardiomyocyte
proliferation, while observations so far in mammals suggest
that Hh signaling is crucial for neovascularization.
Hh signaling has a rather complex effect on the ischemic
heart. Its activation invivo triggers responses in all cardiac cell
populations including cardiomyoblasts, endothelial cells,
smooth muscle cells and epicardial cells. During injury Hh
signaling triggers expressionofpro-angiogenic factors suchas
members of VEGF family (VEGF-A, VEGF-B, and VEGF-
C), Ang-1, Ang-2, and SDF-1 in cardiac fibroblast. It also
participates in repair by promoting cell survival, proliferation
and differentiation. Thus, the alteration of Hh signaling
activity in one cell population leads to changes in other cells.
We, therefore, suggest the following model for Hh-based
cardiac cell–cell interaction (Fig. 2): Hh signaling constitutes
an important mechanism to limit the extent of damage fol-
lowing myocardial ischemia and MI by the coordination of
various factors. Moreover, reductions in Hh signaling worsen
cardiac function and increase infarct size following MI, sug-
gesting that endogenousHh activitymay serve as a biomarker
predictive of the extent of recovery after MI. Altogether, Hh
signaling can be a potential target for stimulating cardiac
regeneration but a more systemic approach like multiscale
analysis to study its role in the heart will be required.
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